What is Zymeworks Inc. Common Stock?
, a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies; and ProTECT, a tumor-specific immune co-stimulation platform. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.85B, and a P/E ratio of 49.5x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 8187,933 shares $4.7M | 0 |